10 news items
Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
CELU
19 Apr 24
. (NASDAQ:CELU) (the "Company"), a regenerative medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial products
Celularity Abstract "Emerging Technologies for the Management and Protection of Tendon Injuries: Decellularized Placental Biomaterials" Accepted at ORS Tendon Conference 2024
CELU
18 Apr 24
"), a regenerative medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial products, today announced that its
Celularity Says That Its Expected Net Sales For Q1 2024 Are Trending Ahead Of The Expectations It Announced In February For Its Advanced Biomaterial Products And Biobanking Businesses; Implements Planned 2024 SG&A Reductions And Manufacturing Ramp For Advanced Biomaterial Products
CELU
15 Apr 24
Inc. (NASDAQ:CELU) ("Celularity") a regenerative medicine company
Celularity Announces Net Sales Trending Ahead of Expectations for First Quarter 2024; Implements Planned 2024 SG&A Reductions and Manufacturing Ramp for Advanced Biomaterial Products
CELU
15 Apr 24
) ("Celularity") a regenerative medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial products, today announced
Celularity To Present Data Showing Senescent Cell Elimination By Off-The-Shelf Natural Killer Cells Derived From Human Placental Cells
CELU
8 Apr 24
the normal regenerative process that restores function to organs and tissues.Celularity is building a broad technology platform that leverages
r8bi2qc7d1x
CELU
8 Apr 24
and tumor progression. Moreover, if not eliminated, these cells impair the normal regenerative process that restores function to organs and tissues
btbs0yx2vobjoskqim mvh6sx2dek
CELU
26 Mar 24
Inc. (NASDAQ:CELU) ("Celularity"), a regenerative medicine
8qjl01sx1n3arjf8ene5rxovx5tu60e57f5awfb
CELU
20 Mar 24
. (NASDAQ:CELU) ("Celularity"), a regenerative medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial
2b3nt3gp9o
CELU
14 Mar 24
and Singularity University Founder. "Dr. Hariri has been a pioneer in cellular and regenerative medicine and his seminal research, some of it going back to his
d69846f85sddca2slpbszwad2p16614
CELU
12 Mar 24
in neuroinflammatory diseases, including multiple sclerosis, and studied the promise of cellular and regenerative therapy in treating age-related cognitive
- Prev
- 1
- Next